Ahmed, M. A., Azam, F., Rghigh, A. M., Gbaj, A., & Zetrini, A. E. (2012). Structure-based design, synthesis, molecular docking, and biological activities of 2-(3-benzoylphenyl) propanoic acid derivatives as dual mechanism drugs. Journal of pharmacy & bioallied sciences, 4(1), 43.
Al-Qahtani, A. A. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): emergence, History, Basic and Clinical Aspects. Saudi journal of biological sciences.
Anand, K., Palm, G. J., Mesters, J. R., Siddell, S. G., Ziebuhr, J., & Hilgenfeld, R. (2002). Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α‐helical domain. The EMBO journal, 21(13), 3213-3224.
Ariffin, F., Heong Chew, S., Bhupinder, K., Karim, A. A., & Huda, N. (2011). Antioxidant capacity and phenolic composition of fermented Centella asiatica herbal teas. Journal of the Science of Food and Agriculture, 91(15), 2731-2739.
Arifuzzaman, M., Hamza, A., Zannat, S. S., Fahad, R., Rahman, A., Hosen, S. Z., ... & Hossain, M. K. (2020). Targeting galectin-3 by natural glycosides: a computational approach. Network Modeling Analysis in Health Informatics and Bioinformatics, 9(1), 1-15.
Azam, F., Amer, A. M., Abulifa, A. R., & Elzwawi, M. M. (2014). Ginger components as new leads for the design and development of novel multi-targeted anti-Alzheimer’s drugs: a computational investigation. Drug design, development and therapy, 8, 2045.
Azam, F., Vijaya Vara Prasad, M., Thangavel, N., Kumar Shrivastava, A., & Mohan, G. (2012). Structure-based design, synthesis and molecular modeling studies of thiazolyl urea derivatives as novel anti-parkinsonian agents. Medicinal Chemistry, 8(6), 1057-1068.
Azerad, R. (2016). Chemical structures, production and enzymatic transformations of sapogenins and saponins from Centella asiatica (L.) Urban. Fitoterapia, 114, 168-187.
Bappy, S. S., Sultana, S., Adhikari, J., Mahmud, S., Khan, M. A., Kibria, K. K., ... & Shibly, A. Z. (2020). Extensive Immunoinformatics study for the prediction of novel peptide-based epitope vaccine with docking confirmation against Envelope protein of Chikungunya virus: A Computational Biology Approach. Journal of Biomolecular Structure and Dynamics, 1-16.
Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., ... & Bourne, P. E. (2000). The protein data bank. Nucleic acids research, 28(1), 235-242.
BIOVIA, D. S. (2015). BIOVIA Discovery Studio Visualizer, v16. 1.0. 15350. San Diego: Dassault Systèmes.
Borkotoky, S., & Banerjee, M. (2020). A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem). Journal of Biomolecular Structure and Dynamics, 1-11.
Bouchentouf, S., & Missoum, N. (2020). Identification of compounds from Nigella sativa as new potential inhibitors of 2019 novel Coronasvirus (COVID-19): Molecular docking study.
Brinkhaus, B., Lindner, M., Schuppan, D., & Hahn, E. G. (2000). Chemical, pharmacological and clinical profile of the East Asian medical plant Centella aslatica. Phytomedicine, 7(5), 427-448.
Bylka, W., Znajdek‐Awiżeń, P., Studzińska‐Sroka, E., Dańczak‐Pazdrowska, A., & Brzezińska, M. (2014). Centella asiatica in dermatology: an overview. Phytotherapy research, 28(8), 1117-1124.
Cao, S. Y., Wang, W., Nan, F. F., Liu, Y. N., Wei, S. Y., Li, F. F., & Chen, L. (2018). Asiatic acid inhibits LPS-induced inflammatory response in endometrial epithelial cells. Microbial pathogenesis, 116, 195-199.
Case, D. A., Cheatham III, T. E., Darden, T., Gohlke, H., Luo, R., Merz Jr, K. M., ... & Woods, R. J. (2005). The Amber biomolecular simulation programs. Journal of computational chemistry, 26(16), 1668-1688.
Chandrika, U. G., & Kumara, P. A. P. (2015). Gotu kola (Centella asiatica): nutritional properties and plausible health benefits. Advances in food and nutrition research, 76, 125-157.
Chen, L., Liu, W., Zhang, Q., Xu, K., Ye, G., Wu, W., ... & Liu, Y. (2020). RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerging microbes & infections, 9(1), 313-319.
Cheng, T., Pan, Y., Hao, M., Wang, Y., & Bryant, S. H. (2014). PubChem applications in drug discovery: a bibliometric analysis. Drug discovery today, 19(11), 1751-1756.
Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports, 7(1), 1-13.
Dash, R., Ali, M., Dash, N., Azad, M., Kalam, A., Hosen, S. M., ... & Moon, I. S. (2019). Structural and dynamic characterizations highlight the deleterious role of SULT1A1 R213H polymorphism in substrate binding. International journal of molecular sciences, 20(24), 6256.
Dong, L., Hu, S., & Gao, J. (2020). Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug discoveries & therapeutics, 14(1), 58-60.
Enmozhi, S. K., Raja, K., Sebastine, I., & Joseph, J. (2020). Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach. Journal of Biomolecular Structure and Dynamics, 1-7.
Fang, Y. (2020). Fang Y, Zhang H, Xie J, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology, 200432.
Gohil, K. J., Patel, J. A., & Gajjar, A. K. (2010). Pharmacological review on Centella asiatica: a potential herbal cure-all. Indian journal of pharmaceutical sciences, 72(5), 546.
Gorbalenya, A. E., Baker, S. C., Baric, R., Groot, R. J. D., Drosten, C., Gulyaeva, A. A., ... & Ziebuhr, J. (2020). Severe acute respiratory syndrome-related coronavirus: The species and its viruses–a statement of the Coronavirus Study Group.
Gray, N. E., Zweig, J. A., Matthews, D. G., Caruso, M., Quinn, J. F., & Soumyanath, A. (2017). Centella asiatica attenuates mitochondrial dysfunction and oxidative stress in Aβ-exposed hippocampal neurons. Oxidative medicine and cellular longevity, 2017.
Gutteridge, W. E. (1991). Control of parasitic diseases: a complementary role for vaccines and drugs. Immunology letters, 30(2), 261-265.
Gyebi, G. A., Ogunro, O. B., Adegunloye, A. P., Ogunyemi, O. M., & Afolabi, S. O. (2020). Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): An in silico screening of alkaloids and terpenoids from African medicinal plants. Journal of Biomolecular Structure and Dynamics, 1-13.
Hafiz, Z. Z., Amin, M., Johari James, R. M., Teh, L. K., Salleh, M. Z., & Adenan, M. I. (2020). Inhibitory effects of Raw-Extract Centella Asiatica (RECA) on Acetylcholinesterase, Inflammations, and oxidative stress activities via in vitro and in vivo. Molecules, 25(4), 892.
Hossain, M. U., Khan, M., Rakib-Uz-Zaman, S. M., Ali, M. T., Islam, M., Keya, C. A., & Salimullah, M. (2016). Treating diabetes mellitus: pharmacophore based designing of potential drugs from Gymnema sylvestre against insulin receptor protein. BioMed research international, 2016.
Hossain, M. U., Oany, A. R., Ahmad, S. A. I., Hasan, M. A., Khan, M. A., & Siddikey, M. A. A. (2016). Identification of potential inhibitor and enzyme-inhibitor complex on trypanothione reductase to control Chagas disease. Computational biology and chemistry, 65, 29-36.
Islam, M. J., Parves, M. R., Mahmud, S., Tithi, F. A., & Reza, M. A. (2019). Assessment of structurally and functionally high-risk nsSNPs impacts on human bone morphogenetic protein receptor type IA (BMPR1A) by computational approach. Computational biology and chemistry, 80, 31-45.
Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., ... & Yang, H. (2020). Structure of M pro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289-293.
Khaerunnisa, S., Kurniawan, H., Awaluddin, R., Suhartati, S., & Soetjipto, S. (2020). Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study.
Kremer, M., & Snyder, C. M. (2003). Why are drugs more profitable than vaccines? (No. w9833). National Bureau of Economic Research.
Krieger, E., & Vriend, G. (2015). New ways to boost molecular dynamics simulations. Journal of computational chemistry, 36(13), 996-1007.
Krieger, E., Darden, T., Nabuurs, S. B., Finkelstein, A., & Vriend, G. (2004). Making optimal use of empirical energy functions: force‐field parameterization in crystal space. Proteins: Structure, Function, and Bioinformatics, 57(4), 678-683.
Krieger, E., Nielsen, J. E., Spronk, C. A., & Vriend, G. (2006). Fast empirical pKa prediction by Ewald summation. Journal of molecular graphics and modelling, 25(4), 481-486.
Kumar, D., Chandel, V., Raj, S., & Rathi, B. (2020). In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach. Chemical Biology Letters, 7(3), 166-175.
Lake, M. A. (2020). What we know so far: COVID-19 current clinical knowledge and research. Clinical Medicine, 20(2), 124.
Licciardi, F., Giani, T., Baldini, L., Favalli, E. G., Caporali, R., & Cimaz, R. (2020). COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country. Pediatric Rheumatology, 18, 1-7.
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced drug delivery reviews, 23(1-3), 3-25.
Liu, T., Wu, S., Tao, H., Zeng, G., Zhou, F., Guo, F., & Wang, X. (2020). Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan-implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2. MedRxiv.
Lobo-Galo, N., Terrazas-López, M., Martínez-Martínez, A., & Díaz-Sánchez, Á. G. (2020). FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication. Journal of Biomolecular Structure and Dynamics, 1-9.
Lou, J., Tian, S. J., Niu, S. M., Kang, X. Q., Lian, H. X., Zhang, L. X., & Zhang, J. J. (2020). Coronavirus disease 2019: a bibliometric analysis and review. Eur Rev Med Pharmacol Sci, 24(6), 3411-21.
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., ... & Tan, W. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The lancet, 395(10224), 565-574.
Maglione, M. A., Das, L., Raaen, L., Smith, A., Chari, R., Newberry, S., ... & Gidengil, C. (2014). Safety of vaccines used for routine immunization of US children: a systematic review. Pediatrics, 134(2), 325-337.
Mahmud, S., Parves, M. R., Riza, Y. M., Sujon, K. M., Ray, S., Tithi, F. A., ... & Absar, N. (2020). Exploring the potent inhibitors and binding modes of phospholipase A2 through in silico investigation. Journal of Biomolecular Structure and Dynamics, 38(14), 4221-4231.
Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. Journal of Biomolecular Structure and Dynamics, 1-6.
Oellien, F., & Nicklaus, M. C. (2004). Online SMILES translator and structure file generator.
Orhan, I. E. (2012). Centella asiatica (L.) Urban: from traditional medicine to modern medicine with neuroprotective potential. Evidence-based complementary and alternative medicine, 2012.
Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y., & Jung, S. H. (2016). An overview of severe acute respiratory syndrome–coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy. Journal of medicinal chemistry, 59(14), 6595-6628.
Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of medicinal chemistry, 58(9), 4066-4072.
Razali, N. N. M., Ng, C. T., & Fong, L. Y. (2019). Cardiovascular protective effects of Centella asiatica and its triterpenes: a review. Planta medica, 85(16), 1203-1215.
Roy, D. C., Barman, S. K., & Shaik, M. M. (2013). Current updates on Centella asiatica: phytochemistry, pharmacology and traditional uses. Medicinal Plant Research, 3.
Sander, T. (2001). OSIRIS property explorer. Organic Chemistry Portal.
Sawatdee, S., Choochuay, K., Chanthorn, W., & Srichana, T. (2016). Evaluation of the topical spray containing Centella asiatica extract and its efficacy on excision wounds in rats. Acta Pharmaceutica, 66(2), 233-244.
Seevaratnam, V., Banumathi, P., Premalatha, M. R., Sundaram, S. P., & Arumugam, T. (2012). Functional properties of Centella asiatica (L.): a review. Int J Pharm Pharm Sci, 4(5), 8-14.
Shushni, M. A. M., Azam, F., & Lindequist, U. (2013). Oxasetin from Lophiostoma sp. of the Baltic Sea: identification, in silico binding mode prediction and antibacterial evaluation against fish pathogenic bacteria. Natural product communications, 8(9), 1934578X1300800909.
Singh, S., Gautam, A., Sharma, A., & Batra, A. (2010). Centella asiatica (L.): a plant with immense medicinal potential but threatened. International journal of pharmaceutical sciences review and research, 4(2), 9-17.
Steinhauer, D. A., & Holland, J. J. (1987). Rapid evolution of RNA viruses. Annual Reviews in Microbiology, 41(1), 409-431.
Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of medicinal chemistry, 45(12), 2615-2623.
Wang, Q., Zhao, Y., Chen, X., & Hong, A. (2020). Virtual screening of approved clinic drugs with main protease (3CLpro) reveals potential inhibitory effects on SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1-11.
Wang, Y., Wang, Y., Chen, Y., & Qin, Q. (2020). Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures. Journal of medical virology, 92(6), 568-576.
Yang, H., Lou, C., Sun, L., Li, J., Cai, Y., Wang, Z., ... & Tang, Y. (2019). admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics, 35(6), 1067-1069.
Yang, H., Xie, W., Xue, X., Yang, K., Ma, J., Liang, W., ... & Rao, Z. (2005). Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol, 3(10), e324.
Yoosook, C., Bunyapraphatsara, N., Boonyakiat, Y., & Kantasuk, C. (2000). Anti-herpes simplex virus activities of crude water extracts of Thai medicinal plants. Phytomedicine, 6(6), 411-419.
Yuan, S., Chan, H. S., & Hu, Z. (2017). Using PyMOL as a platform for computational drug design. Wiley Interdisciplinary Reviews: Computational Molecular Science, 7(2), e1298.
Yuen, K. S., Ye, Z. W., Fung, S. Y., Chan, C. P., & Jin, D. Y. (2020). SARS-CoV-2 and COVID-19: The most important research questions. Cell & bioscience, 10(1), 1-5.
Yuliana, D., Bahtiar, F. I., & Najib, A. (2013). In silico screening of chemical compounds from roselle (Hibiscus Sabdariffa) as angiotensin-I converting enzyme inhibitor used PyRx program. ARPN J. Sci. Technol, 3, 1158-1160.
Zahara, K., Bibi, Y., & Tabassum, S. (2014). Clinical and therapeutic benefits of Centella asiatica. Pure and Applied Biology, 3(4), 152.
Zhang, D. H., Wu, K. L., Zhang, X., Deng, S. Q., & Peng, B. (2020). In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. Journal of integrative medicine, 18(2), 152-158.
Zhavoronkov, A., Aladinskiy, V., Zhebrak, A., Zagribelnyy, B., Terentiev, V., Bezrukov, D. S., ... & Ivanenkov, Y. (2020). Potential COVID-2019 3C-like protease inhibitors designed using generative deep learning approaches. Insilico Medicine Hong Kong Ltd A, 307, E1.
Zheng, M. S. (1989). An experimental study of the anti-HSV-II action of 500 herbal drugs. Journal of traditional Chinese medicine= Chung i tsa chih ying wen pan, 9(2), 113-116.
Zhou, D., Dai, S. M., & Tong, Q. (2020). COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. Journal of Antimicrobial Chemotherapy, 75(7), 1667-1670.
Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W., ... & Shi, Z. L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature, 579(7798), 270-273.